ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancerP. Tarantino, G. Curigliano, V. Diéras et al.|Annals of Oncology|2023Cited by 298
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: A multicentre Hellenic Cooperative Oncology Group phase II studyGeorge Pentheroudakis, Nikolaos Pavlidis, Haralabos P. Kalofonos et al.|Acta Oncologica|2008Cited by 34